Gilead Sciences has announced the signing of voluntary licencing agreements with six generic pharmaceutical manufacturers to ...

The collaboration supports efforts for HIV prevention through PrEP, emphasizing Hetero’s commitment to improving HIV care.

Gilead signs non-exclusive, royalty-free voluntary licensing agreements with six generic companies to market its ...

Ferozsons Laboratories Limited (PSX: FEROZ) has entered into a non-exclusive voluntary license agreement with Gilead Sciences ...

Gilead Sciences is granting licenses to six companies to produce lenacapavir for pre-exposure prophylaxis, as well as for ...

It is one of six global partners to have signed a voluntary licence agreement with Gilead to produce a high-quality generic ...

If approved, the six manufacturers – Dr Reddy’s Laboratories Limited, Emcure, Eva Pharma, Ferozsons Laboratories Limited, ...

Emcure Pharmaceuticals has partnered with Gilead Sciences Ireland UC to manufacture and distribute generic lenacapavir for ...

Ferozsons Laboratories Limited (Ferozsons), a Pakistani pharmaceutical, has entered into a non-exclusive voluntary license ...

Six drugmakers sign agreements with Gilead Sciences to produce generic lenacapavir, a long-acting HIV drug, amid patent ...

HIV expert Linda-Gail Bekker talks to The Conversation Weekly about promising results from a trial of a new drug for HIV ...

Lenacapavir was approved for use in HIV-positive adults with multi-drug resistance by the European Union in August 2022 and ...